Protein kinase C (PKC) plays important roles in the signaling cascade from the epidermal growth factor (EGF) receptor to the nucleus. EGFactivates tyrosine kinase of the EGFreceptor which leads to autophosphorylation on carboxyl-terminal tyrosine residues, phosphorylation of phospholipase Cr, and subsequent hydrolysis of phosphatidylinositol (23). Another rapid response following EGFbinding to its receptor is the increased expression of a set of "early-response genes" (19) . Twoof these are the proto-oncogenes c-fos and cjun. c-fos and c-jun gene products are nuclear proteins and form a heterodimer or a homodimercomplex with AP-1 activity (17) , which activates transcription of certain genes through interaction with their promoter region (15, 18) . Regulation of c-fos and c-jun gene expression involves protein kinase(s) including PKC. Thus, the use of specific kinase inhibitors mayprovide additional insight to dissect the role of PKCin signal transduction pathways to the nucleus. Among the PKC inhibitors, calphostin-C, a secondary metabolite of the fungus Cladosporium cladosporioides (21) , possesses several unique features. First, calphostin-C interacts with the diacylglycerol binding site of PKC (16) , while other inhibitors such as staurosporine interact with the catalytic site (21) . Since the catalytic site is more conserved throughout protein kinase families and the diacylglycerol binding site is unique to PKC, the inhibition by calphostin-C is assumed to be more specific for PKCthan other kinase inhibitors. A unique feature of calphostin-C is that the inhibition of PKC in vitro is light-dependent (4). The light-dependency results from photo-dynamic activation of perylenequinone structure of calphostin-C to generate active oxygen, followed by the oxidative modification of PKC (10).
In addition to the inhibition of PKC, another unique feature of calphostin-C is the enhancement of the EGF receptor phosphorylation on serine and threonine residues in a light-dependent manner but rather PKC-independent oxidative reaction (8) . To further characterize the biological consequences of this unique receptor phosphorylation, we examined the effect of calphostin-C on the expression of early-response genes c-fos and cjun and found that calphostin-C stimulated the expression of these genes in a light-dependent manner. This finding suggests that calphostin-C in vivo acts as a potent activator of a signal transduction pathway to earlyresponse gene expression.
MATERIALS AND METHODS
Cell culture. Humanlung adenocarcinoma cell line A549 (12) decanoylphorbol 13-acetate (TPA) (10 ng/ml). EGFreceptorphosphorylation. EGF receptor phosphorylation and immunoprecipitationanalysis was carried out as described previously (6, 7, 13) . A549 cells were labeled with [32P] orthophosphate (3.7 MBq/ml, carrier-free, ICN Biomedicals, Irvine, CA, USA) in DMEMcontaining one-tenth concentration of phosphate and supplemented with dialyzed fetal calf serum for 4 h. Cells were then treated with calphostin-C and lysed in Triton X-100 lysis buffer (1% Triton X-100, 1 mM EDTA, 150mMNaCl, 50mMTris-HCl, pH7.4, 0.1 mM phenylmethylsulfonyl fluoride). The lysates were clarified by centrifugation and the supernatants were incubated with antihuman EGF receptor antibody (B4G7) (2) bound to protein A-Sepharose (Pharmacia-LKB Biotechnology, Uppsala, Sweden) for 4 h. The receptor-antibody complex on the Sepharose was washed extensively and analyzed by electrophoresis on a SDS-polyacrylamide gel (7%). Autoradiography and quantitation of radioactivity was carried out using a BAS2000Bio-imaging analyzer (Fuji Photo Film, Tokyo, Japan). Northern blot analysis. Northern blot analysis was carried out as described previously (9) . In brief, cellular RNAswere extracted by the LiCl-urea method (1 transcription analysis was carried out as described (1 1) Cells were further treated with EGF, TPAor calphostin-C for 15 min under light, and lysed for the immunoprecipitation using anti-human EGF receptor monoclonal antibody B4G7. The immunoprecipitates were analyzed by SDS-polyacrylamide gel (7%) electrophoresis, followed by autoradiography in a BAS2000 Bio-imaging analyzer.
to remove nuclei and cell debris, the lysates were centrifuged at 100,000 rpm for 15 min in a Beckman TLA100.2 rotor and the supernatants were used as the cytosolic fraction. PKCactivity in the cytosolic fraction was assayed using histone as a substrate. For in vitro assay, PKCwas partially purified from the cytosolic fraction of A549 cells by DE52-cellulose chromatography. After calphostin-C/light treatment in the presence or absence of Ca^(1 mM)for 15min on ice, PKCactivity was assayed. A549 cells were treated with calphostin-C for 30 min or 60 min (top), or with calphostin-C and/or EGFfor 30 min (bottom). The cells were then lysed to isolate the nuclei. The isolated nuclei were labeled with [a-32P]CTP, and nuclear transcripts were extracted by the LiCl/urea method. The plasmid DNAcontaining c-fos and c-jun CDNAand the pUC18vector plasmid DNAwere immobilized on a nylon membrane with a dot-blot apparatus. Hybridization of labeled nuclear transcripts with DNAs on the membrane, washing and autoradiography were carried out as Northern blot analysis described in Fig. 2 .
RESULTS

Calphostin
Calphostin-C under light enhanced receptor phosphorylation 2-to 3-fold regardless of the presence of EGFor TPA (Fig. 1) . However, another PKCinhibitor, staurosporine completely inhibited TPA-induced receptor phosphorylation, but not EGF-induced receptor phosphorylation, suggesting staurosporine specifically inhibits PKC.EGFreceptor phosphorylation was on serine and threonine residues and maximalat 30 min after calphostin-C treatment under light (data not shown). Furthermore, EGF receptor phosphorylation induced by calphostin-C was not inhibited by staurosporine (Fig.  1) , suggesting that PKCis not involved in the EGF receptor phosphorylation process. A549 cells were treated with calphostin-C (Cal-C) and staurosporine (Sts) under light. At the indicated times, RNAswere extracted and Northern blot analysis using c-fos CDNAprobe was carried out as described in Fig. 2 . O , calphostin-C added at 0 min; à" , staurosporine added at -30 min and then calphostin-C added at 0 min; A , calphostin-C added at 0 min and then staurosporine added at 30 min; A , calphostin-C added at 0 min and then staurosporine added at 60 min.
treated with calphostin-C (the decrease was approximately 10%of control and statistically insignificant).
Whencells were treated first with calphostin-C for 30 min and then with calphostin-C and staurosporine for another 30 min, cytosolic PKCactivity decreased to a level similar to that in staurosporine-treated cells. TPA also reduced cytosolic PKCactivity because of its binding to the PKCregulatory domain and subsequent translocation to the plasma membrane.Whencells were first treated with calphostin-C and then with calphostin-C and TPA, PKCactivity decreased to a level similar to that in the TPA-treated cells.
Next, the effect of staurosporine on calphostin-C /light induction of early-response gene expression was examined by Northern blot analysis. Whenstaurosporine was added prior to calphostin-C, no c-fos mRNA accumulation was observed (Fig. 6) . Thus, these results together suggest that unlike the case in vitro, PKC remains in the cytosolic fraction after calphostin-C/light treatment in vivo and this remaining cytosolic PKCapparently plays an important role(s) in the induction of early-response gene expression by calphostin-C. DISCUSSION We described novel light-dependent cellular responses to calphostin-C, which is known to inhibit PKC in vitro through interaction with diacylglycerol binding domain of PKC (16) . In vitro studies demonstrate that the side chain of calphostin correlates with its PKCinhibition activity (16) and the perylenequinone ring confers photo-reactive oxidizing activity. Thus, calphostin-C induces oxidative inactivation of PKC at the Ca^-induced hydrophobic site (10). Staurosporine was assumed to be less specific to PKCbecause of its binding to the catalytic domain of PKC (21) . However, in our study, staurosporine specifically inhibited the PKC-mediated responses such as phosphorylation of the EGFreceptor in response to TPAand phosphorylation of the 80K protein (MARCKS) (8), a major cytosolic substrate for PKC (14, 20) .
In contrast to staurosporine, calphostin-C in vivo does not seem to target cytosolic PKC. One possibility for the lack of PKCinhibition in vivo is that PKCmay be altered in A549cells so that it is insensitive to cal- Another possibility is that cytosolic PKC is apparently more resistant to calphostin-C than membranebound PKC. Lipophilic calphostin-C readily accumulates in the membrane (24), and membrane-bound PKC is rapidly inactivated while cytosolic PKC is not (10). Further, the magnitude of cytosolic PKCinactivation seems different among cell lines and is dependent on a cytosolic scavenger mechanismwhichprotects cytosolic PKC from radicals (10). Thus, it is likely that membrane-accumulated calphostin-C generates active oxygen in a light-dependent reaction, enhances the EGFreceptor phosphorylation, and subsequently activates the cytosolic PKC-dependent signal transduction pathway to early-response gene expression. This process for calphostin-C activation of signaling pathway is different from the pathway triggered by the EGFreceptor tyrosine kinase and therefore apparently causes a unique kinetics of c-fos mRNA accumulation.
Our findings include several unique features for gene regulation by calphostin-C, including light-dependent induction and possible involvement of PKC. To overcome the paradox that a protein kinase inhibitor induces phosphorylation and subsequent gene expression, wehypothesize that light-dependent oxidation on the plasma membraneis a triggering reaction of these unique cellular responses. Further elucidation of this hypothesis should provide insights not only in the regulation of early-response gene expression but also in the growth factor receptor phosphorylation mechanism.
